


| Key | % Net Assets |
|---|---|
| 4.5% | |
| 4.4% | |
| 4.4% | |
| 4.0% | |
| 82.7% |
| Name | % Net Assets |
|---|---|
| UBS | 4.5% |
| Novartis | 4.4% |
| BNP Paribas | 4.4% |
| DnB NOR Bank | 4.0% |
| Roche Holding | 3.8% |
| Brenntag | 3.5% |
| Hexagon | 3.5% |
| Assa Abloy | 3.4% |
| Svenska Cellulosa | 3.3% |
| Henkel | 3.3% |
| Key | % Net Assets |
|---|---|
| 20.00% | |
| 18.60% | |
| 17.50% | |
| 16.80% | |
| 16.50% |
| Date | 27-Mar-2025 |
|---|---|
| NAV | 104.80p |
| Currency | GBP |
| Change | -1.60p |
| % | -1.50% |
| YTD change | 10.84p |
| YTD % | 11.54% |
| Fund Inception | 03/10/2003 |
|---|---|
| Fund Manager | n/a |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 0.75% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research